Opioid Prescribing to US Children and Young Adults in 2019
Recent national data are lacking on the prevalence, safety, and prescribers of opioid prescriptions dispensed to children and young adults aged 0 to 21 years. More
Recent studies in antibiotic stewardship
A single-center study of terminal cancer patients found a high rate of antibiotic use within the last 30 days of life, with significantly lower use among those who asked for limited antimicrobial treatment, researchers reported yesterday in Open Forum Infectious Diseases. More
The COVID-19 Pandemic and Drug Prescribing in Ontario Nursing Homes
The pharmacoepidemiologic study by Campitelli et al examined changes in medication prescribing in nursing homes in Ontario, Canada, during the first wave of the COVID-19 pandemic. More
Facing Headwinds on New Alzheimer’s Drug, Biogen Launches Controversial Campaign
Do you sometimes lose your train of thought or feel a bit more anxious than is typical for you? Those are two of the six questions in a quiz on a website co-sponsored by the makers of Aduhelm, a controversial new Alzheimer’s drug. But even when all responses to the frequency of those experiences are “never,” the quiz issues a “talk to your doctor” recommendation about the potential need for additional cognitive testing. More
Expert panel votes unanimously that Biogen Alzheimer’s drug doesn’t offer patient benefits
The 15-to-0 vote on the Alzheimer's drug Aduhelm amounted to a rebuke of both Biogen and the Food and Drug Administration. More
Cleveland Clinic and Mount Sinai Won’t Administer Aduhelm to Patients
The rejection of the new Alzheimer’s drug by the two major medical centers is one of the starkest signs of concern over its approval by the F.D.A. More
Nearly One in Four People Say Their Medications are Not Routinely Reviewed and Evaluated by Their Medical Team
Today, The Get the Medications Right™ (GTMRx) Institute is sharing the results of a new survey that assesses the medication management habits and needs of over 1,000 people. Among the findings, nearly one quarter of people surveyed cited that their medications are not routinely reviewed and evaluated by their medical team—a shocking fact, given that one-third are taking four or more medications and/or supplements per day. More
(PDF) The Spread in Hospital Chargemaster Prices for Common Drugs
How New Hospital Transparency Regulations Fall Short More
Prohibited, unlisted, even dangerous ingredients turn up in dietary supplements
Consumers may think they’re safer or more “natural” than pharmaceuticals, but multiple studies show they are sometimes adulterated with medicines and unknown additives. More
A crucial, overlooked question on the new Alzheimer’s drug: When should patients stop taking it?
Doctors told STAT it will be critical — and exceedingly difficult — to determine whether Aduhelm's effects are waning with time. More